A global platform for translational medicine, guided by scientific integrity and international collaboration.
NBIIC-HI is pleased to collaborate with Nankai University in advancing international research cooperation through core laboratory collaboration.
Built on shared interests in life sciences, biomedical research, and healthcare innovation, this collaboration reflects NBIIC-HI's commitment to connecting research, innovation, clinical collaboration, and global partnerships.
The Core Laboratory serves as a platform for academic exchange, interdisciplinary research, and future translational collaboration.
Nankai University is one of China's leading universities with strong strengths in life sciences and biomedical research.
Through this collaboration, NBIIC-HI and Nankai University aim to promote:
This collaboration supports NBIIC-HI's broader development pathway:
It also represents an important step in strengthening international cooperation in healthcare-related research and innovation.
Through this collaboration, NBIIC-HI continues to build an international platform for research, innovation, and healthcare partnership.
NBIIC-HI collaborates with China-based nanomedicine and bioconjugation technical partners to support translational biomedical research, early-stage innovation, and preclinical validation. Through this collaboration, NBIIC-HI integrates international project design, clinical problem identification, scientific writing, partner coordination, and commercialization planning with advanced experimental execution capabilities in China.
The platform supports research teams in nanomedicine, drug delivery, LNP/RNA delivery, exosome engineering, molecular imaging, smart biomaterials, bioconjugation, preclinical validation, and customized research-use-only detection kit development.
This brochure includes detailed technical service capabilities, customized RUO research kit development options, preclinical validation services, and international collaboration models.